Cargando…

KRAS mutation‐independent downregulation of MAPK/PI3K signaling in colorectal cancer

KRAS is a gatekeeper gene in human colorectal tumorigenesis. KRAS is ‘undruggable’; hence, efforts have been diverted to inhibit downstream RAF/MEK/ERK and PI3K/Akt signaling. Nevertheless, none of these inhibitors has progressed to clinical use despite extensive trials. We examined levels of phosph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Kuen Kuen, Tang, Choong Leong, Tan, Emile, Wong, Siew Heng, Cheah, Peh Yean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895447/ https://www.ncbi.nlm.nih.gov/pubmed/34919787 http://dx.doi.org/10.1002/1878-0261.13163

Ejemplares similares

KRAS-specific antibody binds to KRAS protein inside colorectal adenocarcinoma cells and inhibits its localization to the plasma membrane
por: Lam, Kuen Kuen, et al.
Publicado: (2023)

Targeting the ‘Undruggable’ Driver Protein, KRAS, in Epithelial Cancers: Current Perspective
por: Lam, Kuen Kuen, et al.
Publicado: (2023)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

Chromosome 19q13 disruption alters expressions of CYP2A7, MIA and MIA-RAB4B lncRNA and contributes to FAP-like phenotype in APC mutation-negative familial colorectal cancer patients
por: Thean, Lai Fun, et al.
Publicado: (2017)

Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells
por: Wang, Zaozao, et al.
Publicado: (2021)

Association of Caucasian-Identified Variants with Colorectal Cancer Risk in Singapore Chinese
por: Thean, Lai Fun, et al.
Publicado: (2012)

Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
por: Temraz, Sally, et al.
Publicado: (2015)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways
por: Zhang, Jinjun, et al.
Publicado: (2018)

Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling
por: Adams, Lauren M., et al.
Publicado: (2022)

Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation
por: Shen, Chih-Jie, et al.
Publicado: (2023)

Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways: Erratum
por: Zhang, Jinjun, et al.
Publicado: (2023)

KSR induces RAS‐independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors
por: Paniagua, Guillem, et al.
Publicado: (2022)

Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status
por: Lee, Jeeyun, et al.
Publicado: (2014)

Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways
por: Hu, Zhiyan, et al.
Publicado: (2020)

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
por: Vitiello, Pietro Paolo, et al.
Publicado: (2019)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy
por: Chen, Kuen-Feng, et al.
Publicado: (2015)

Correction to: Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways
por: Hu, Zhiyan, et al.
Publicado: (2020)

Expression of Adenine Nucleotide Translocator Correlates with the IL-4-induced lymphocyte survival: Role of PI3K and MAPK
por: Jang, Ji-Young, et al.
Publicado: (2001)

Ceramide synthase CERS4 gene downregulation is associated with KRAS mutation in colorectal cancer
por: Hayama, Tamuro, et al.
Publicado: (2023)

Targeting the PI3K signaling pathway in KRAS mutant colon cancer
por: Hong, Suntaek, et al.
Publicado: (2015)

Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers
por: Fernandes, Maria Sofia, et al.
Publicado: (2016)

Platycodin D sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the PI3K/Akt signaling pathway
por: Liu, Yanfei, et al.
Publicado: (2022)

MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
por: Kharbanda, Akriti, et al.
Publicado: (2014)

Supercritical Fluid Extract of Spent Coffee Grounds Attenuates Melanogenesis through Downregulation of the PKA, PI3K/Akt, and MAPK Signaling Pathways
por: Huang, Huey-Chun, et al.
Publicado: (2016)

First Report of Eurycoma longifolia Jack Root Extract Causing Relaxation of Aortic Rings in Rats
por: Tee, Bae Huey, et al.
Publicado: (2016)

PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
por: Corrales, Eyleen, et al.
Publicado: (2022)

Model-independent search for $CP$ violation in $D^{0} \to K^{-}K^{+}\pi^{-}\pi^{+}$ and $D^{0} \to \pi^{-}\pi^{+}\pi^{+}\pi^{-}$ decays
por: Aaij, R, et al.
Publicado: (2013)

Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71
por: Wong, Wen-Rou, et al.
Publicado: (2005)

KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K–MAPK1 inhibition
por: Janardhan, Harish Palleti, et al.
Publicado: (2020)

Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis
por: Wong, Carlos KH, et al.
Publicado: (2014)

Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways
por: Liu, Yao, et al.
Publicado: (2021)

Clinical features and KRAS mutation in colorectal cancer with bone metastasis
por: Park, Hyung Soon, et al.
Publicado: (2020)

Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia
por: Chung, Wen-Cheng, et al.
Publicado: (2019)

Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status
por: Blagoev, Krastan B., et al.
Publicado: (2017)

Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery
por: Wong, Chun-Ming, et al.
Publicado: (2011)

Realgar-induced KRAS mutation lung cancer cell death via KRAS/Raf/MAPK mediates ferroptosis
por: Liu, Xiaofeng, et al.
Publicado: (2022)

A search for direct CP violation in $K^{\pm} \to \pi^{\pm} \pi^{\mp}$ decays
por: Choong, W.-S.
Publicado: (2013)

Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways
por: Yang, Tingfang, et al.
Publicado: (2016)

A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo
por: Yan, Zheng, et al.
Publicado: (2021)

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amaq1i6002pdfff6oujau86gqs